These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29856192)

  • 21. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

  • 22. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proton pump inhibitor H2 receptor antagonist].
    Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
    Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

  • 25. Aging and upper gastrointestinal disorders.
    Pilotto A
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():73-81. PubMed ID: 15588798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
    Rew JS
    Korean J Gastroenterol; 2006 Mar; 47(3):181-90. PubMed ID: 16554671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic trends of diseases of the upper gastrointestinal tract in patients with negative H. pylori status].
    Watari J; Sakurai J; Morita T; Oshima T; Hori K; Miwa H
    Nihon Rinsho; 2009 Dec; 67(12):2378-86. PubMed ID: 19999128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
    O'Connor HJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current use of proton pump inhibitors and when to limit, stop or not start treatment].
    Helgadottir H; Bjornsson ES
    Laeknabladid; 2023 Jul; 109(708):338-345. PubMed ID: 37378651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Indications, Applications, and Risks of Proton Pump Inhibitors.
    Mössner J
    Dtsch Arztebl Int; 2016 Jul; 113(27-28):477-83. PubMed ID: 27476707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
    Lazzaroni M; Porro GB
    Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication].
    Ballesteros-Amozurrutia MA
    Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabeprazole for the treatment of acid-related disorders.
    Marelli S; Pace F
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):423-35. PubMed ID: 22928894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
    Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG
    Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evidence and uncertainties on the clinical use of proton pump inhibitors].
    de Prados CM
    Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.